AstraZeneca will contribute both funding and a post-doctoral scientist to the Brindle Group.
The global biologics research and development arm of AstraZeneca will contribute both funding and a post-doctoral scientist to work within the laboratory of Kevin Brindle in the area of tumour targeted therapies. Read the full story on the main University news website.